SEC Form D · filed November 22, 2021
RedHill Biopharma Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (39)
Guy D. Goldberg · Tel Aviv, L3ExecKenneth Reed · Tel Aviv, L3DirectorOfer Tsimchi · Tel Aviv, L3DirectorAdi D. Frish · Tel Aviv, L3ExecAlla D. Felder · Tel Aviv, L3DirectorRick D. Scruggs · Tel Aviv, L3Exec · DirectorJune D. Almenoff · Tel Aviv, L3ExecMicha D. Ben Chorin · Tel Aviv, L3ExecGilead D. Raday · Tel Aviv, L3ExecReza D. Fathi · Tel Aviv, L3ExecEric Swenden · Tel Aviv, L3DirectorShmuel Cabilly · Tel Aviv, L3DirectorDror Ben-Asher · Tel Aviv, L3Exec · DirectorMichael B. Rozmajzl · Roswell, GAExecGreg Schupra · Pontiac, MIExecJoshua E. Wyss · Mill Valley, CADirectorBrandon Contino · Turtle Creek, PAExecCleon N. Daskalakis · Boston, MAExecMohamed Arafa · Amstelveen, P7DirectorJeffrey N. Vale · Atlanta, GAExecIngrid Mulder · Amstelveen, P7Exec · DirectorGaurav Gambhir · Philadelphia, PADirectorKen Johnson · Franklin, MIDirectorAldo Zini · Turtle Creek, PADirectorPeter R. Kagan · Tulsa, OKExecBruce W. Snyder · Seattle, WAExec · DirectorJosh S. Stein · Palo Alto, CADirectorJesse S. Robbins · Palo Alto, CAExecSteven A. Anderson · SOUTH PASADENA, CADirectorJohn C. Power · VACAVILLE, CAExec · DirectorBrian C. Power · VACAVILLE, CADirectorLee Shapiro · Northbrook, ILExecJacob S. Horne · SAN FRANCISCO, CAExecDavid Meredith · NEWPORT BEACH, CAExecRick Taketa · CORONA DEL MAR, CAExecDarren O'Brien · WAN CHAI, Hong KongDirectorSimone Blank · NEWPORT BEACH, CAExec · DirectorJost Fischer · NEWPORT BEACH, CADirectorDouglas Buchalter · Asheville, NCExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗